Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease
Steven A. Harris, Elizabeth Harris
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Herpes Simplex Virus-1 in the Brain: The Dark Side of a Sneaky Infection
Maria Elena Marcocci, Giorgia Napoletani, Virginia Protto, et al.
Trends in Microbiology (2020) Vol. 28, Iss. 10, pp. 808-820
Open Access | Times Cited: 220
COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Xiaohuan Xia, Yi Wang, Jialin Zheng
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 119
The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota
Friedrich Leblhuber, Daniela Ehrlich, Kostja Steiner, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 361-361
Open Access | Times Cited: 108
Infectious agents and Alzheimer's disease
Thomas Piekut, Mikołaj Hurła, Natalia Banaszek, et al.
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 2
Open Access | Times Cited: 88
Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
Vanesa R. Hyde, Chaoming Zhou, J R Muñóz y Fernández, et al.
Cell Reports (2025), pp. 115109-115109
Open Access | Times Cited: 7
Time to test antibacterial therapy in Alzheimer’s disease
Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Brain (2019)
Open Access | Times Cited: 140
Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease
Morgane Linard, Luc Letenneur, Isabelle Garrigue, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 1, pp. 200-208
Open Access | Times Cited: 106
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
Hongmei Li, Chia‐Chen Liu, Hui Zheng, et al.
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 90
Viral Involvement in Alzheimer’s Disease
Ahmad M Sait, Cristian Angeli, Andrew J. Doig, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1049-1060
Open Access | Times Cited: 69
Identifying health conditions associated with Alzheimer's disease up to 15 years before diagnosis: an agnostic study of French and British health records
Thomas Nedelec, Baptiste Couvy‐Duchesne, Fleur Monnet, et al.
The Lancet Digital Health (2022) Vol. 4, Iss. 3, pp. e169-e178
Open Access | Times Cited: 55
Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia
Pardis Zarifkar, Costanza Peinkhofer, Michael E. Benros, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 49
Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone
Erin E. Sundermann, Matthew S. Panizzon, Xu Chen, et al.
Biology of Sex Differences (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 69
Infectious hypothesis of Alzheimer disease
Charles E Seaks, Donna M. Wilcock
PLoS Pathogens (2020) Vol. 16, Iss. 11, pp. e1008596-e1008596
Open Access | Times Cited: 65
Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons
Rebecca D. Powell-Doherty, Amber Abbott, Laura A. Nelson, et al.
Journal of Virology (2020) Vol. 94, Iss. 9
Open Access | Times Cited: 50
Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids
Gill Diamond, Natalia Molchanova, Claudine Herlan, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 304-304
Open Access | Times Cited: 47
The Causes and Long-Term Consequences of Viral Encephalitis
Karen Böhmwald, Catalina A. Andrade, Nicolás M. S. Gálvez, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 46
Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Showkat Ul Nabi, Andleeb Khan, Ehraz Mehmood Siddiqui, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-28
Open Access | Times Cited: 33
The intestinal microbial metabolite nicotinamide n-oxide prevents herpes simplex encephalitis via activating mitophagy in microglia
Feng Li, Yiliang Wang, Xiaowei Song, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 30
A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex–associated Alzheimer's disease
Karin Lopatko Lindman, Bodil Weidung, Jan Olsson, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2019) Vol. 5, Iss. 1, pp. 697-704
Open Access | Times Cited: 48
EDTA Chelation Therapy for the Treatment of Neurotoxicity
Alessandro Fulgenzi, Maria Elena Ferrero
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1019-1019
Open Access | Times Cited: 46
Alzheimer disease and the periodontal patient: New insights, connections, and therapies
Mark I. Ryder, Pinelopi Xenoudi
Periodontology 2000 (2021) Vol. 87, Iss. 1, pp. 32-42
Closed Access | Times Cited: 36
Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer’s disease
Shu Feng, Yongzhen Liu, Yu Zhou, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 16
Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers
Mohammad Azam Ansari, Takshashila Tripathi, Baskar Venkidasamy, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 3042-3089
Closed Access | Times Cited: 14
Insights into the Novel Therapeutics and Vaccines against Herpes Simplex Virus
Shiza Malik, Ranjit Sah, Omar Ahsan, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 325-325
Open Access | Times Cited: 13
Infections, Genetics, and Alzheimer's Disease: Exploring the Pathogenic Factors for Innovative Therapies
Ramesh Kordi, T. John Andrews, Mark D. Hicar
Virology (2025), pp. 110523-110523
Closed Access
Page 1 - Next Page

Scroll to top